Phase II Trial of Oral Topotecan and Intravenous Carboplatin With G-CSF Support in Previously Untreated Patients With Extensive Stage Small Cell Lung Cancer
- Citation:
- Am J Clin Oncol vol 33 (4) 353-357
- Year:
- 2010
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- U10 CA052352, U10 CA037417, N01 CA035431, U10 CA035269, CA-37404, CA-35431, CA-52352, CA-35195, U10 CA037404, U10 CA063848, U10 CA035195, CA-35103, CA-25224, U10 CA035272, CA-35113, U10 CA035113, CA-63848, U10 CA063849, U10 CA035431, CA-37417, CA-35272, CA-35269, U10 CA025224, CA-63849, U10 CA035103
- Corr. Author:
- Authors:
- Alan H. Bryce Bassam Mattar Shauna L. Hillman Alex A. Adjei John W. Kugler Kendrith Rowland Donald B. Wender Gamini Soori Edith A. Perez James R. Jett
- Networks:
- Study
- NCCTG-0027
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- small cell lung cancer, topotecan, filgastrim, phase II